In a time of increasingly personalized healthcare, Elizabeth Philp has become a leading force of innovation, especially in the technologically advancing field of compounded pharmacy. As the chief executive and co-founder of Roseway Labs, Philp is at the helm of a movement to make bespoke medications more available, disrupting the conventional one-